Metabolic Signaling Research

Metabolic signaling research covers the receptor systems and enzymatic pathways through which cells sense nutrient availability and regulate substrate use. Compounds in this category are studied in preclinical models for their interaction with incretin receptor families, nicotinamide N-methyltransferase, and downstream glucose- and lipid-handling pathways. The group includes both peptide analogs characterized for receptor binding across single and multiple incretin pathways, and small-molecule enzyme inhibitors such as 5-Amino-1MQ, which is investigated as a selective NNMT inhibitor in NAD+ and methylation-pathway research. Each lot is supplied with a batch-specific certificate of analysis. Identity is confirmed by mass spectrometry and purity quantified by HPLC-UV, with the lot number on the vial matching the COA on file. All products in this category are supplied strictly for laboratory research use. They are not drugs, not dietary supplements, and are not for human or veterinary use.